These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15250065)

  • 41. The role of alendronate in mitigating perimenopausal bone loss: a double-blind randomized controlled pilot study.
    Mersereau JE; Khouri C; Jaffe RB
    Fertil Steril; 2010 Aug; 94(3):1138-40. PubMed ID: 20056199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postmenopausal osteoporosis.
    Diab DL; Watts NB
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):501-9. PubMed ID: 24150190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [FACT study: benefits of alendronate].
    MMW Fortschr Med; 2005 Jan; 147(1-2):52-3. PubMed ID: 15704574
    [No Abstract]   [Full Text] [Related]  

  • 44. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention and treatment of osteoporosis in women with breast cancer.
    Mincey BA; Moraghan TJ; Perez EA
    Mayo Clin Proc; 2000 Aug; 75(8):821-9. PubMed ID: 10943237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strategies for the prevention and treatment of osteoporosis during early postmenopause.
    Delaney MF
    Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S12-23. PubMed ID: 16448872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alendronate in the treatment of osteoporosis.
    Adami S
    Aging (Milano); 1998 Apr; 10(2):159-60. PubMed ID: 9666215
    [No Abstract]   [Full Text] [Related]  

  • 48. Results of special studies with alendronate.
    McClung M
    Int J Clin Pract Suppl; 1999 Apr; 101():67-72. PubMed ID: 12669743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
    Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
    N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alendronate in the treatment of postmenopausal osteoporosis.
    Hosking DJ; Favus M; Yates AJ
    Int J Clin Pract Suppl; 1999 Apr; 101():27-35. PubMed ID: 12669738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.
    Adachi JD
    Can Fam Physician; 1998 Feb; 44():327-32. PubMed ID: 9512836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Basic aspects of osteoporosis therapy with active vitamin D metabolites].
    Schacht E
    Med Klin (Munich); 1996 Feb; 91 Suppl 1():34-7. PubMed ID: 8839112
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK₂) in postmenopausal RA patients.
    Suzuki K; Tsuji S; Fukushima Y; Nakase T; Hamada M; Tomita T; Yoshikawa H
    Mod Rheumatol; 2013 May; 23(3):450-5. PubMed ID: 22692649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term therapy for postmenopausal osteoporosis: stronger bones but weaker arteries.
    Goldstein MR
    Circulation; 1999 Jul; 100(4):446-7. PubMed ID: 10447376
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical inquiries. Do calcium supplements prevent postmenopausal osteoporotic fractures?
    Campbell BG; Ketchell D; Gunning K
    J Fam Pract; 2003 Mar; 52(3):234, 237. PubMed ID: 12620181
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of male osteoporosis: recent advances with alendronate.
    Ringe JD; Orwoll E; Daifotis A; Lombardi A
    Osteoporos Int; 2002 Mar; 13(3):195-9. PubMed ID: 11991437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treating Low Vitamin D Levels Is Ineffective in Postmenopausal Women.
    Shaughnessy AF
    Am Fam Physician; 2016 Feb; 93(4):315. PubMed ID: 26926821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.